Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 16Amgen Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
ChemOutsourcing
Not Confirmed
arrow
ChemOutsourcing
Not Confirmed

Denosumab

Brand Name : XGEVA

Patent Number : 2285746

Filing Date : 1998-04-15

Strength per Unit : 120 mg / 1.7 ml

Dosage Form : solution

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2018-04-15

Date Granted : 2010-09-28

blank

02

arrow
ChemOutsourcing
Not Confirmed
arrow
ChemOutsourcing
Not Confirmed

Denosumab

Brand Name : XGEVA

Patent Number : 2274987

Filing Date : 1997-12-22

Strength per Unit : 120 mg / 1.7 ml

Dosage Form : solution

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2017-12-22

Date Granted : 2012-01-24

blank

03

arrow
ChemOutsourcing
Not Confirmed
arrow
ChemOutsourcing
Not Confirmed

Denosumab

Brand Name : XGEVA

Patent Number : 2328140

Filing Date : 1999-05-13

Strength per Unit : 120 mg / 1.7 ml

Dosage Form : solution

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2019-05-13

Date Granted : 2012-03-13

blank

04

arrow
ChemOutsourcing
Not Confirmed
arrow
ChemOutsourcing
Not Confirmed

Denosumab

Brand Name : PROLIA

Patent Number : 2257247

Filing Date : 1998-04-15

Strength per Unit : 60 mg / mL

Dosage Form : prefilled syringe

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2018-04-15

Date Granted : 2012-09-11

blank

05

arrow
ChemOutsourcing
Not Confirmed
arrow
ChemOutsourcing
Not Confirmed

Denosumab

Brand Name : PROLIA

Patent Number : 2400929

Filing Date : 2001-02-23

Strength per Unit : 60 mg / mL

Dosage Form : prefilled syringe

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2021-02-23

Date Granted : 2011-05-31

blank

06

arrow
ChemOutsourcing
Not Confirmed
arrow
ChemOutsourcing
Not Confirmed

Denosumab

Brand Name : PROLIA

Patent Number : 2274987

Filing Date : 1997-12-22

Strength per Unit : 60 mg / mL

Dosage Form : prefilled syringe

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2017-12-22

Date Granted : 2012-01-24

blank

07

arrow
ChemOutsourcing
Not Confirmed
arrow
ChemOutsourcing
Not Confirmed

Denosumab

Brand Name : PROLIA

Patent Number : 2285746

Filing Date : 1998-04-15

Strength per Unit : 60 mg / mL

Dosage Form : prefilled syringe

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2018-04-15

Date Granted : 2010-09-28

blank

08

arrow
ChemOutsourcing
Not Confirmed
arrow
ChemOutsourcing
Not Confirmed

Denosumab

Brand Name : PROLIA

Patent Number : 2257247

Filing Date : 1998-04-15

Strength per Unit : 60 mg / mL

Dosage Form : vial

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2018-04-15

Date Granted : 2012-09-11

blank

09

arrow
ChemOutsourcing
Not Confirmed
arrow
ChemOutsourcing
Not Confirmed

Denosumab

Brand Name : PROLIA

Patent Number : 2400929

Filing Date : 2001-02-23

Strength per Unit : 60 mg / mL

Dosage Form : vial

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2021-02-23

Date Granted : 2011-05-31

blank

10

arrow
ChemOutsourcing
Not Confirmed
arrow
ChemOutsourcing
Not Confirmed

Denosumab

Brand Name : PROLIA

Patent Number : 2274987

Filing Date : 1997-12-22

Strength per Unit : 60 mg / mL

Dosage Form : vial

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2017-12-22

Date Granted : 2012-01-24

blank